C
Pfizer Inc. PFE
$25.19 $0.150.60% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

09/28/2025 06/29/2025 03/30/2025 12/31/2024 09/29/2024
Revenue 3.90% 13.54% 11.65% 6.84% -12.76%
Total Other Revenue -- 200.00% -- -99.95% -99.95%
Total Revenue 3.89% 13.54% 11.65% 6.84% -12.76%
Cost of Revenue 34.68% 5.92% -0.65% -7.71% -55.18%
Gross Profit -3.53% 16.51% 16.61% 13.04% 13.04%
SG&A Expenses -0.87% -0.65% 2.86% 6.56% 4.23%
Depreciation & Amortization -3.66% 0.63% 5.08% 11.68% 12.99%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 8.11% 0.98% 0.88% 0.50% -25.29%
Operating Income -5.47% 68.02% 59.13% 30.72% 39.08%
Income Before Tax 134.43% 353.01% 512.40% 658.32% -62.52%
Income Tax Expenses -70.40% 85.31% 66.82% 97.49% -346.67%
Earnings from Continuing Operations 128.45% 520.13% 3,208.66% 270.50% -59.02%
Earnings from Discontinued Operations 245.45% 1,300.00% 176.19% 173.33% -269.23%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -28.13% -33.33% 14.71% 20.51% 15.79%
Net Income 131.14% 514.34% 2,651.13% 279.00% -59.44%
EBIT -5.47% 68.02% 59.13% 30.72% 39.08%
EBITDA -4.75% 42.14% 38.37% 24.39% 30.87%
EPS Basic 130.93% 511.31% 2,595.87% 275.63% -59.80%
Normalized Basic EPS -5.72% 60.71% 41.74% 4.92% 15.23%
EPS Diluted 132.16% 504.53% 2,229.80% 297.64% -59.43%
Normalized Diluted EPS -5.81% 60.47% 41.73% 5.44% 17.13%
Average Basic Shares Outstanding 0.33% 0.34% 0.35% 0.37% 0.43%
Average Diluted Shares Outstanding 0.39% 0.61% 0.49% 0.30% -0.37%
Dividend Per Share 2.40% 2.41% 2.42% 2.44% 2.45%
Payout Ratio -0.67% 1.19% 1.04% -0.73% 1.54%